IONS IONIS PHARMACEUTICALS, INC.
Research report · from SEC EDGAR · close 2026-07-13
$56.75 -2.6%
$9.38B mkt cap
executive summary
IONIS PHARMACEUTICALS, INC. (IONS) is a $9.38B company. Revenue is $943.7M (+33.8% y/y) at a -35% net margin. It is not yet profitable. Our health score is D (44/100). 2 red flags on file. Held by 1 tracked funds. It funds itself; low dilution risk.
Revenue (FY)
$943.7M
+33.8% y/y
⛔Bankruptcy-risk zone
Altman Z-Score is in the distress zone (1.47).
⚠One-sided insider selling
16 insider sales and no open-market buys in the recent window.
who's buying
Insider buys / sells
0 / 16
Cash & ST investments
$1.92B
Operating cash flow
-$268.6M
Dilution shelf
active shelf
FILINGReg FD disclosure
8-K filed 2026-07-10
FILINGReg FD disclosure
8-K filed 2026-07-09
Assembled from SEC EDGAR (XBRL, Form 4, 13F, filings), STOCK Act disclosures, and end-of-day prices — every figure is real and sourced; nothing is fabricated or predicted. Filings lag 40–90 days. Educational, not investment advice. Generated 2026-07-13 by stocktools.ai.